1. Home
  2. AUPH vs CLB Comparison

AUPH vs CLB Comparison

Compare AUPH & CLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

N/A

Current Price

$15.85

Market Cap

2.2B

Sector

Health Care

ML Signal

N/A

Logo Core Laboratories Inc.

CLB

Core Laboratories Inc.

N/A

Current Price

$9.05

Market Cap

414.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
AUPH
CLB
Founded
1993
1936
Country
Canada
United States
Employees
N/A
3300
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
414.2M
IPO Year
2014
2023

Fundamental Metrics

Financial Performance
Metric
AUPH
CLB
Price
$15.85
$9.05
Analyst Decision
Buy
Buy
Analyst Count
7
3
Target Price
★ $18.29
$15.00
AVG Volume (30 Days)
★ 862.3K
625.5K
Earning Date
10-30-2026
10-28-2026
Dividend Yield
N/A
★ 0.44%
EPS Growth
★ N/A
N/A
EPS
★ 0.76
0.23
Revenue
$283,055,000.00
★ $526,520,000.00
Revenue This Year
$16.65
N/A
Revenue Next Year
$17.73
$2.52
P/E Ratio
★ $21.29
$39.30
Revenue Growth
N/A
★ 0.51
52 Week Low
$13.52
$8.61
52 Week High
$19.25
$20.36

Technical Indicators

Market Signals
Indicator
AUPH
CLB
Relative Strength Index (RSI) 41.44 36.26
Support Level $15.67 N/A
Resistance Level $16.48 $10.76
Average True Range (ATR) 0.55 0.42
MACD -0.11 -0.06
Stochastic Oscillator 6.56 20.23

Price Performance

Historical Comparison
AUPH
CLB

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About CLB Core Laboratories Inc.

Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.

Share on Social Networks: